Everest Organics Ltd Share Price Today - Everest Organics Ltd Stock Price Live NSE/BSE

Everest Organics Ltd

NSE: BSE: 524790

₹362.65

(-3.16%)

Tue, 10 Mar 2026, 10:10 pm

MTF 5xInvest in Everest Organics Ltd with 5x Leverage Buy with MTF

Market Cap3.52B

PE Ratio60.40

Dividend0

Distribution Services

Medical Distributors

24.5K

Everest Organics Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
271.99
Net Profit
-1.29
P/B
3.55
Sector P/E
40.49
P/E
0
EV/EBITDA
36.15
Debt/Equity (Industry)
0.16
Interest Cover (Industry)
20.20
ROCE (Industry)
20.50
RONW (Industry)
17.60
ROE
-2.23
ROCE
1.72
Debt/Equity
0.91
EPS (TTM)
6
Dividend Yield
0
Book Value
74.67
Interest Cover
0.38

Analysis

all

Pros

Dividends paid are thoroughly covered by earnings (9.9x coverage).
Everest Organics's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
Everest Organics is profitable, therefore cash runway is not a concern.
Everest Organics is profitable, therefore cash runway is not a concern.
Debt is well covered by operating cash flow (49.5%, greater than 20% of total debt).

Cons

Everest Organics only just started paying a dividend, it is too early to tell if payments are increasing.
It is too early to tell whether Everest Organics has stable dividend payments.
Everest Organics's dividend is below the markets top 25% of dividend payers in India (3.08%).
Everest Organics's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
Everest Organics's level of debt (74%) compared to net worth is high (greater than 40%).

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	59.61	59.64	60.99	61.09	74.15
FII	0	0	0	0	0
DII	0.02	0.02	0.02	0.02	0.05
Public	40.37	40.33	38.98	38.89	25.80
Government	0	0	0	0	0

Technical Analysis

RSI

38.31

MACD

-32.61

50 DMA

410.43

200 DMA

398.42

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	664.88	512.08	437.37	359.28	284.57	206.48	53.68
Fibonacci	512.08	453.71	417.65	359.28	300.91	264.85	206.48
Camarilla	404.67	390.66	376.66	359.28	348.64	334.64	320.63

Pivots Level: Classic

+305.60

664.88

+152.80

512.08

+78.08

437.37

359.28

Pivot Point

LTP: 303.25

-74.72

284.57

-152.80

206.48

-305.60

53.68

Moving Average

SMAEMA

Period

Value

10-EMA
316.25
20-EMA
342.78
30-EMA
361.76
50-EMA
384.43
100-EMA
399.58
200-EMA
382.32

Announcement Date	Purpose	Action	Ex Date
11 Feb 2026	board-meetings	Quarterly Results
05 Aug 2025	agm
16 Dec 2024	egm
16 Sept 2024	agm
17 Aug 2023	agm
11 Aug 2022	agm
27 May 2022	dividend	₹0.50 Dividend /Share	17 Sept 2022
05 Aug 2021	agm
12 Jun 2021	dividend	₹1.00 Dividend /Share	11 Sept 2021
08 Feb 2021	dividend	₹0.50 Dividend /Share	18 Feb 2021

Everest Organics Ltd

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd

Cipla Ltd

Divis Laboratories Ltd

Dr Reddys Laboratories Ltd

Everest Organics Ltd About

Everest Organics is principally engaged in manufacturing of active pharmaceutical ingredients and Bulk drugs.

Industry

Pharmaceuticals - Indian - Bulk Drugs

Founded

1993

Headquarters

CEO

SUNDARA PRASAD VENKATA SATYA SRIKAKOLAPU

Employees

Contact

Website

http://www.everestorganicsltd.com

eolcs0405@gmail.com

Phone

91-8455-250113

Location

Aroor Village, Sadasivpet Mandal, Medak, Telangana, 502291

Year	History
1993	The company was incorporated on 19th February The company obtained the certificate of commencement of business on 17th March
1995	The plant went into commercial production by July The plant was initially scheduled to go into commercial production by the end of September
2020	Everest Organics successfully develops Remdesivir API

Client Name	Order Side	QTY	Avg Price	Date
BK LEGACY TRUST	Sell	55824	402.5	13 Jun 2025
JAY JANAK JESRANI	Buy	49414	270.02	03 Apr 2025
MADRAS PARAMESWARAN MANOJ MAHADEV	Buy	43082	206	21 Aug 2019

Everest Organics Ltd News

Everest Organics Board Approves Q3FY26 Results

Everest Organics Limited's Board of Directors approved unaudited financial results for the quarter and nine months ended December 31, 2025, in a meeting held on February 14, 2026.

14 Feb 2026

co actions results

Everest Organics Postal Ballot Results December 2025

Everest Organics Limited announces successful completion of postal ballot with three special resolutions passed with 99.99% approval, including director appointments and designation changes.

12 Dec 2025

stocks

Everest Organics Seeks Shareholder Approval for Board Restructuring Through Postal Ballot

Everest Organics Limited has issued a postal ballot notice seeking shareholder approval for three special resolutions including appointment of Mr. Venkata Satya Subbarao Pachigolla as Whole-Time Director with Rs. 2,00,000 monthly remuneration and designation changes for two existing directors. The remote e-voting period runs from November 17, 2025 to December 16, 2025, with results to be declared by December 18, 2025.

15 Nov 2025

corporate action

Everest Organics Reports Profit Turnaround in Q2 FY2026, Announces Board Changes

Everest Organics Limited reported a profit of Rs 59.47 lakhs for the quarter ended September 30, 2025, compared to a loss of Rs 634.96 lakhs in the previous year quarter. Revenue from operations increased to Rs 10,022.53 lakhs from Rs 7,210.48 lakhs year-on-year. For the half-year period, the company posted a profit of Rs 256.10 lakhs versus a loss of Rs 929.03 lakhs in the corresponding previous period. The Board approved the appointment of Venkata Satya Subbarao Pachigolla as Additional Director (Whole-time Director), subject to shareholder approval through postal ballot. The company also announced designation changes for two existing directors - Kirankumar Rampally will move from Non-Executive Non-Independent to Independent Director, while Prasad Venkata Satya Sundara Srikakolapu will change from Independent Director to Non-Executive Non-Independent. The auditor's report highlighted two qualification issues: the company is operating at enhanced production levels without necessary approvals from Telangana State Pollution Control Board, and has not provided for Rs 143 lakhs in interest claimed by suppliers for delayed payments.

13 Nov 2025

earnings

Everest Organics Board Approves Re-appointment of Key Directors and New Company Secretary

Everest Organics Limited's Board of Directors approved the re-appointment of Dr. Srikakarlapudi Sirisha as Managing Director for three years from August 10, 2025 to August 09, 2028, and Mr. Srikakarlapudi Harikrishna as Whole-time Director for three years from September 25, 2025 to September 24, 2028. Both appointments are subject to shareholder approval at the 32nd Annual General Meeting. The board also appointed Ms. Shweta Singh as Company Secretary and Compliance Officer effective August 05, 2025. Dr. Sirisha, 48, holds M.B.B.S and MD degrees and has been with the company since 2014, also serving as CEO. Mr. Harikrishna, 46, is a mechanical engineer who joined in 2007 and brings expertise in project planning and engineering. Both directors are promoters and related to each other. Ms. Singh is an associate member of the Institute of Company Secretaries of India with over 3 years of compliance experience.

05 Aug 2025

corporate governance

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800